Matches in Nanopublications for { ?s ?p "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496220.RADSqmxbkVnbWScrOUKpEf8mUOa3O3O3KERKa4XSwNspk130_provenance.
- NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_provenance.
- NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903033.RAbhBFJIrrMtzWvLtrg0sE2u0cIaFLDTkwz_jb_vy5DhE130_provenance.
- NP957908.RA04jmQBawVIhVx4Uq0ybn2N5Gh6_t6VXB0oM8c9f4iYI130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957908.RA04jmQBawVIhVx4Uq0ybn2N5Gh6_t6VXB0oM8c9f4iYI130_provenance.
- NP957909.RA-cCrcMOZVWcIra8LEfkZqi6Qq_0bup6mJeA_55aL2KI130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957909.RA-cCrcMOZVWcIra8LEfkZqi6Qq_0bup6mJeA_55aL2KI130_provenance.